Align Technology Inc Stock Price, News & Analysis

Align Technology (ALGN) has announced that its Invisalign® brand is becoming an Official Partner of Bay FC, a professional soccer franchise in the National Women's Soccer League (NWSL). The partnership includes the creation of 'Legends of Confidence' content series featuring Bay FC players undergoing Invisalign treatment, sharing their smile journeys.

The collaboration will feature an entitlement night at Bay FC's match against Chicago Stars on April 13 at PayPal Park, including fan activities and giveaways. The partnership also focuses on expanding youth sports access across the Bay Area through community events and initiatives. Bay FC strikers Racheal Kundananji and midfielder Tess Boade have already kicked off the campaign on the team's Instagram.

Align Technology (NASDAQ: ALGN) has launched Align X-ray Insights, an AI-powered computer-aided detection software, in the EU and UK. The solution, which automatically analyzes 2D radiographs, will be showcased at the 2025 IDS Dental Show in Cologne.

The software, part of the Align Digital Platform, helps doctors diagnose dental and oral health conditions through AI detection of caries, periapical radiolucencies, and periodontal bone loss. Early user surveys showed 95% of doctors found it helpful in communicating oral health conditions, while 91% reported improved patient trust and treatment acceptance.

The desktop/tablet version will be available from March 25, 2025, with iTero scanner integration planned for release. The software has received regulatory clearance in Europe, UK, Canada, and New Zealand, with pending approvals in other markets including US FDA 510K clearance. A 60-day free trial is being offered as part of the launch.

Align Technology (NASDAQ: ALGN) has announced enhanced restorative capabilities for its next-generation iTero Lumina™ intraoral scanner and new iTero Lumina™ Pro dental imaging system. The upgraded solutions feature comprehensive capabilities for dental practices, including Near Infra-Red Imaging (NIRI) technology in the Pro version.

The systems are powered by iTero Multi-Direct Capture™ technology offering 3x larger field of view and 25mm maximum capture distance, enabling 2x faster scanning compared to previous models. Key features include superior full jaw clinical accuracy, ability to scan within accuracy threshold of photogrammetry for full-arch implant restorations, and up to 5 capabilities in one device.

The iTero Lumina™ scanner is currently available in multiple regions including the US, Canada, EU, and various Asian countries, while the Pro version is available in select markets. Both systems will be rolled out to additional locations throughout 2025, pending regulatory approvals.

Align Technology (ALGN) has announced plans to repurchase $225 million of its common stock through open market repurchases, completing its $1.0 billion stock repurchase program approved in January 2023.

CFO John Morici stated this decision reflects the company's strong balance sheet, cash flow generation, and management's confidence in capitalizing on market opportunities while providing shareholder value. The repurchases will be executed via a Rule 10b5-1 trading plan and are expected to be completed by early May 2025, funded with Align's cash on hand.

As of December 31, 2024, Align had approximately 73.8 million shares outstanding and $1,043.9 million in cash and cash equivalents. The company continues to focus on making its Invisalign® System the standard of care in orthodontics through its doctor-centered model.

Align Technology (NASDAQ: ALGN) announced that its Invisalign Palatal Expander System has received approval from the Turkish Medicines and Medical Device Agency (TMMDA) and is now available in Turkey. The system offers a removable, safe alternative to traditional palatal expanders for skeletal and dental expansion in patients of all ages.

The system consists of customized 3D-printed devices designed using iTero intraoral scans and proprietary orthodontic software. Combined with Invisalign First™ aligners, it provides a complete early intervention treatment solution for Phase 1 treatment, which represents 20% of orthodontic case starts annually.

The expansion devices are created in small increments to gradually expand a patient's narrow maxilla (upper jaw). This innovation enhances Align's digital orthodontics portfolio, offering doctors improved efficiency and patients better treatment experiences in the EMEA region.

Align Technology (ALGN) reported Q4 2024 total revenues of $995.2 million, up 4.0% year-over-year, with full-year 2024 revenues reaching $4.0 billion, up 3.5% from 2023. Q4 Clear Aligner volumes increased 6.1% year-over-year, while Systems and Services revenues grew 14.9%.

The company's Q4 operating margin was 14.5%, with diluted EPS of $1.39 (GAAP) and $2.44 (non-GAAP). Full-year 2024 operating margin was 15.2%, with diluted EPS of $5.62 (GAAP) and $9.33 (non-GAAP). Foreign exchange impacts negatively affected 2024 revenues by approximately $38.5 million.

Notable achievements include reaching 271,600 active Invisalign trained practitioners and treating 19.5 million patients globally. The company repurchased $352.9 million of common stock in 2024 and ended the year with $1,043.9 million in cash and cash equivalents.

Align Technology (NASDAQ: ALGN) has announced that NFL quarterback Patrick Mahomes has joined the Invisalign Smile Squad as a brand ambassador. Through a multi-year agreement, Mahomes will share his personal experience with Invisalign clear aligners through a multi-channel campaign.

The Invisalign Smile Squad, launched in 2017, is part of Align's strategy to increase awareness and educate consumers about Invisalign treatment benefits. The program collaborates with regional and global influencers who share their Invisalign treatment journeys across social media platforms including TikTok, Instagram, YouTube, and Snapchat.

Mahomes, the Kansas City Chiefs quarterback, chose Invisalign aligners over traditional braces, citing his focus on optimizing performance and health as an athlete.

Align Technology (ALGN) has announced it will release its fourth quarter and 2024 financial results on Wednesday, February 5, 2025, after market close at 4:00 p.m. ET. The company will host a conference call at 4:30 p.m. ET to discuss the results, which will also be available as a live audio webcast.

The company has also revealed its tentative earnings release dates for fiscal 2025: Q1 on April 30, Q2 on July 30, and Q3 on October 29. Align Technology is a global medical device company specializing in the Invisalign® System, iTero™ intraoral scanners, and exocad™ CAD/CAM software, serving over 271,000 doctor customers and having treated approximately 18.9 million patients with the Invisalign System over 27 years.

Align Technology has received CE Mark in Europe and MHRA registration in the UK for its Invisalign® Palatal Expander System. This innovative 3D-printed device offers a removable alternative to traditional palatal expanders for treating narrow maxilla in patients with primary, mixed, or permanent dentition. Combined with Invisalign First™ aligners, it provides doctors with a complete early intervention treatment solution for both skeletal and dental arch expansion. The system is approved for broad patient applicability, including growing children, teens, and adults. The product is expected to be commercially available across EMEA in Q1 2025.